HomeIPOPhychem TechnologiesFinancials

Phychem Technologies IPO Financials, Risk Factors, Peers & Objects of Issue

An investor-focused breakdown of the Phychem Technologies IPO offer document: restated financial performance, key ratios, valuation across the price band, competitive strengths, risk factors, listed peers, objects of the issue and the business model, all drawn from the company's RHP disclosures.

Back to the Phychem Technologies IPO report → (allotment, subscription, GMP)

Phychem Technologies IPO Financial Performance (Restated)

On a restated consolidated basis, the company revenue increased by 12% and profit after tax (PAT) rose by 44% between the financial year ending with March 31, 2026, a useful one-line read on operating momentum heading into the listing.

Here is how the books have moved over the last three financial years:

31 Mar 2026 to 31 Mar 2024₹ Crore
Particulars31 Mar 202631 Mar 202531 Mar 2024
Assets25.3220.7517.83
Total Income57.4851.1147.59
Profit After Tax4.092.841.69
EBITDA6.094.372.76
Net Worth13.799.706.86
Reserves6.259.416.57
Total Borrowings5.914.595.61

All figures in ₹ Crore unless stated otherwise. Source: restated financials disclosed in the offer documents.

Profits have scaled from ₹1.69 Cr to ₹4.09 Cr over two years; the borrowings-to-net-worth ratio has eased to about 0.43. For investors, the trend matters more than any single year, steady compounding with contained leverage is what institutional bidders typically reward, while a late spike in borrowings deserves scrutiny against the stated objects of the issue.

Phychem Technologies IPO Key Performance Indicators (KPI)

ROE34.82%
RoCE32.73%
Return on Net Worth29.66%
Debt / Equity0.43
NAV per share18.29
Price to Book4.20

Reading these numbers. RoE and RoCE measure how efficiently the business turns shareholder capital into profit; anything in double digits is respectable, mid-twenties plus is strong. A debt-to-equity ratio well below 1 signals a balance sheet that does not depend on lenders. NAV per share anchors the book value of your bid, while price-to-book tells you how many rupees the issue is charging for each rupee of that book, compare it with listed peers in the same sector before deciding whether the premium is justified.

Phychem Technologies IPO Valuation, Pre IPO vs Post IPO

The issue price converts into a different earnings multiple once the fresh shares hit the books. Here is the dilution-adjusted picture:

EPS (₹)5.42→ 3.99 post-IPO
P/E (x)9.96→ 13.53 post-IPO
Market Cap at offer₹41Cr→ ₹55.30 Cr post-IPO

Pre-IPO figures are computed on the pre-issue share count; post-IPO figures assume full subscription at the upper band.

Phychem Technologies IPO Competitive Strengths (as disclosed in the RHP)

Key strengths

Phychem Technologies IPO Business Model

Phychem Technologies IPO Industry Snapshot

Phychem Technologies IPO Objects of the Issue

Repayment in full or in part, of certain of our outstanding borrowings25.00
Funding the capital expenditure towards procurement of plant and machinery51.49
Funding to meet working capital requirements30.00
General Corporate Purpose[●]

Phychem Technologies IPO Litigation

Disclaimer: The financial data on this page is auto-extracted from the company's offer document (RHP/DRHP) and is provided for education only. DostIpo is not a SEBI-registered investment adviser; verify all figures against the official prospectus before making any investment decision. Investments in the securities market are subject to market risks.

View the complete Phychem Technologies IPO report: allotment status, subscription, GMP & review →

Last updated: 02 Sep 2026, 22:23 IST